FO Smith

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

Eric L. Sievers, F R Appelbaum, Ricardo Spielberger et al. · Blood · 1999 · 456 citations

Medicine, Oncology, Pharmacology +14

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

Eric L. Sievers, Frederick R. Appelbaum, Ricardo Spielberger et al. · Blood · 1999 · 439 citations

Medicine, Oncology, Pharmacology +14

The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23

FO Smith, Claudine Rauch, DE Williams et al. · Blood · 1996 · 131 citations · Full text

Medicine, Hematology, Oncology +15

Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891

FO Smith, Todd A. Alonzo, Robert B. Gerbing et al. · Leukemia · 2005 · 123 citations

Medicine, Hematology, Oncology +16

Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance

FO Smith, BC Lampkin, C Versteeg et al. · Blood · 1992 · 74 citations · Full text

Medicine, Hematology, Oncology +13